BigHat Biosciences
Pre-clinicalBigHat Biosciences designs safer, more effective antibody therapies for patients using machine learning and synthetic biology.
Founded
2019
Focus
AI / Machine LearningAntibodiesBiologics
About
BigHat Biosciences designs safer, more effective antibody therapies for patients using machine learning and synthetic biology.
Funding History
3Total raised: $97.5M
Series B$75MSection 32Jan 15, 2023
Series A$19MSection 32May 15, 2021
Seed$3.5MAndreessen HorowitzOct 15, 2019
Company Info
TypePrivate
Founded2019
LocationSan Mateo, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile